Genus Capital Management’s Lam Research LRCX Stock Holding History

Genus Capital Management’s Portfolio LRCX Stock Details LRCX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.9M	Sell	34,333 -7,225	-17%	-$2.19M	1.46%	15
2026 Q1	$8.88M	Sell	41,558 -44,112	-51%	-$9.86M	1.02%	28
2025 Q4	$14.7M	Sell	85,670 -47,890	-36%	-$7.45M	1.71%	13
2025 Q3	$17.9M	Sell	133,560 -15,160	-10%	-$1.61M	2.08%	7
2025 Q2	$14.5M	Buy	+148,720	New	+$11.8M	1.84%	12
2024 Q2	–	Sell	-16,090	Closed	-$1.54M	–	305
2024 Q1	$1.56M	Buy	+16,090	New	+$1.42M	0.2%	126
2023 Q4	–	Sell	-25,940	Closed	-$1.77M	–	303
2023 Q3	$1.63M	Sell	25,940 -58,000	-69%	-$3.81M	0.26%	105
2023 Q2	$5.4M	Buy	+83,940	New	+$4.73M	0.79%	36

Other funds holding LRCX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Genus Capital Management's LRCX Position: Q2 2026 in Review

Genus Capital Management reduced its Lam Research (LRCX) stake by 17% in Q2 2026, selling an estimated $2.19M and leaving 34,333 shares worth $14.9M. The position accounts for 1.46% of the portfolio, ranked #15.

Genus Capital Management first reported a position in LRCX in Q2 2023 and has held it in 8 quarters since. The position peaked at $17.9M in Q3 2025. 3,118 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

Genus Capital Management held 34,333 shares of Lam Research worth $14.9M as of Q2 2026.
Genus Capital Management sold 7,225 Lam Research shares in Q2 2026, an estimated $2.19M.
Lam Research made up 1.46% of Genus Capital Management's portfolio in Q2 2026, its #15 holding.
Genus Capital Management first reported a position in Lam Research in Q2 2023 and has held it in 8 quarters since.
Genus Capital Management's Lam Research position peaked at $17.9M in Q3 2025.
3,118 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Genus Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.